Italia markets open in 43 minutes

FibroGen, Inc. (0IL8.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
52,55+41,63 (+381,23%)
Alla chiusura: 06:44PM BST
Schermo intero
Chiusura precedente10,92
Aperto11,00
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno11,00 - 11,00
Intervallo di 52 settimane11,00 - 11,00
Volume0
Media VolumeN/D
Capitalizzazione3,714B
Beta (5 anni mensile)0,90
Rapporto PE (ttm)N/D
EPS (ttm)-3,04
Prossima data utili08 ago 2022 - 12 ago 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    FibroGen to Participate at William Blair Biotech Focus Conference 2022

    SAN FRANCISCO, July 01, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the William Blair Biotech Focus Conference 2022 taking place the week of July 11, 2022. A webcast of the event will be available Monday, July 11 at 9:00am ET on the “Events & Presentations” section of the FibroGen Investors webpage at www.fibrogen.com. The replay will be available for approximately 30 days. About Fib

  • GlobeNewswire

    FibroGen Announces Completion of Patient Enrollment in LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Duchenne Muscular Dystrophy

    - 73 Ambulatory DMD Patients Enrolled -- Topline Data Anticipated 2H:2023 - SAN FRANCISCO, June 08, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced completion of patient enrollment for LELANTOS-2, a Phase 3 clinical study of pamrevlumab in patients with ambulatory Duchenne muscular dystrophy (DMD). “We are very pleased to complete enrollment of our second Phase 3 study of pamrevlumab in patients with DMD,” said Mark Eisner, M.D, M.P.H, Chief Medical Officer, FibroGen. “Ped

  • GlobeNewswire

    FibroGen to Present at Jefferies Healthcare Conference

    SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 9 at 1:30pm EDT. A live audio webcast of the event will be available on the “Events & Presentations” section of the FibroGen Investors webpage at www.fibrogen.com. A replay will be available for approximately 30 days. About FibroGen FibroGen, Inc. is a biopharmaceu